Indegene has launched a new center in London. This aligns with the company’s long-term growth strategy in Europe, reiterating its commitment to enable life sciences clients in the region to be future-ready.
Indegene’s Europe-based clients can now benefit from this center as a strategic hub for consulting and commercialization solutions and modernize their operations with an AI-first approach. The company is strengthening its existing employee base in the region, with skillsets spanning a wide range of areas-consulting, creative, data and analytics, engineering and customer experience.
Indegene provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1735.45 |
Dr. Reddys Lab | 1144.05 |
Cipla | 1441.70 |
Lupin | 2026.50 |
Zydus Lifesciences | 885.70 |
View more.. |